Teniposide
Top View
- Chemogenomic Screening Identifies the Hsp70 Co-Chaperone HDJ2 As
- Amendment Protocol Number: 09C0195-X Reference Number: 365264
- Teniposide Injection
- Computationally Predicting Clinical Drug Combination Efficacy With
- Combined Paclitaxel and Gemcitabine As First-Line Treatment in Metastatic Non-Small Cell Lung Cancer: a Multicentre Phase II Study
- Arsenic Trioxide Circumvents Multidrug Resistance Based on Different Mechanisms in Human Leukemia Cell Lines
- VUMON® (Teniposide Injection)
- Paclitaxelebeweinj.Pdf
- Analysis of Long-Term Survivors of Glioblastoma Multiforme in a Single Institution with Aggressive Local Retreatment Protocol
- Camptothecin, Teniposide, Or 4
- Chemogenomic Screening Identifies the Hsp70 Co-Chaperone DNAJA1
- BRAIN CANCER TREATMENT REGIMENS (Part 1 of 9) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
- TAXOL (Paclitaxel) INJECTION Rx Only (Patient Information Included)
- Mechanisms of Resistance to Etoposide and Teniposide in Acquired Resistant Human Colon and Lung Carcinoma Cell Lines'
- Cytotoxic Therapy)
- Hair Loss (Alopecia)
- Guideline for Classification of the Acute Emetogenic Potential of Antineoplastic Medication in Pediatric Cancer Patients
- Topoisomerase II Inhibitors